Xiaoge Zhou

Investment in Enterprise Resource Planning: Business Impact and Productivity Measures

Lorin M. Hitt, Dazhong Wu, Xiaoge Zhou · Journal of Management Information Systems · 2002 · 889 citations

Business, Information Systems, Management Information Systems +17

Immunohistochemical Analysis of Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, and Clear Cell Carcinoma: An Optimal and Practical Panel for Differential Diagnosis

Lina Liu, Junqi Qian, Harpreet Singh et al. · Archives of Pathology & Laboratory Medicine · 2007 · 162 citations

Medicine, Oncology, Pathology +17

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories

Emina Torlakovic, Carol C. Cheung, Corrado D’Arrigo et al. · Applied immunohistochemistry & molecular morphology · 2017 · 64 citations

Medicine, Biotechnology, Method Validation +15

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers

Carol C. Cheung, Corrado D’Arrigo, Manfred Dietel et al. · Applied immunohistochemistry & molecular morphology · 2016 · 59 citations

Medicine, Pathology, Diagnostic Pathology +14

EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction

Kristian Sandvej, Xiaoge Zhou, Stephen Hamilton‐Dutoit · The Journal of Pathology · 2000 · 42 citations

Medicine, Molecular Biology, Oncology +16